Westfield Capital Management
OCRX

Westfield Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Westfield Capital Management’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-85,982
Closed -$405K – 321
2015
Q1 		$405K Buy
85,982
+20,700
+32% +$119K ﹤0.01% 292
2014
Q4 		$416K Hold
65,282
– – ﹤0.01% 301
2014
Q3 		$320K Buy
+65,282
New +$377K ﹤0.01% 288

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Westfield Capital Management's OCRX Position: Q2 2015 in Review

Westfield Capital Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2015, closing a stake of 85,982 shares — an estimated $405K sold.

Westfield Capital Management first reported a position in OCRX in Q3 2014 and held it in 3 quarters. The position peaked at $416K in Q4 2014. 32 funds tracked by Wall St. Rank hold OCRX as of Q2 2015.

  • Westfield Capital Management reported no remaining Ocera Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Westfield Capital Management sold 85,982 Ocera Therapeutics, Inc. shares in Q2 2015, an estimated $405K.
  • Westfield Capital Management first reported a position in Ocera Therapeutics, Inc. in Q3 2014 and held it in 3 quarters.
  • Westfield Capital Management's Ocera Therapeutics, Inc. position peaked at $416K in Q4 2014.
  • 32 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2015.

Based on Westfield Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.